• +1 (416) 597-3422 ext.7800
  • kite@uhn.ca

Drug Discovery in Neuroscience Conference

Keynote lecture to be given by Dr. Barbara Tate, Venture Partner at the Dementia Discovery Fund (former Senior Director, Neuroscience, Pfizer).

Join us at 8:00 am for registration and breakfast.

OPENING REMARKS from Dr. Donald Weaver, Director, Krembil Research Institute, and Dr. Bradly Wouters, EVP, Science and Research, University Health Network

NEUROSCIENCE DRUG DISCOVERY IN ACADEMIA

Dr. Janice Robertson

Dr. Jeremy Sivak

Dr. Neil Vasdev

Dr. James Eubanks

Dr. Graham Collingridge

PHARMACOKINETICS IN DRUG DESIGN

Dr. Leanne Bedard

Dr. Samuel Chuang

Dr. Mark Reed

INTELLECTUAL PROPERTY AND COMMERCIALIZATION

Dr. Christopher Barden

HIGH THROUGHPUT SCREENING: TECHNOLOGY AND CASE STUDY

Dr. Juha Kammonen

Dr. Christopher Fladd and Dr. Rodolfo Gomez

Dr. Christopher Marshall and Dr. Genevieve Seabrook

ARTIFICIAL INTELLIGENCE AND DRUG DESIGN

Dr. Vijay Shahini

Dr. Michael Menden

Dr. Igor Jurisica

PANEL DISCUSSION: IS YOUR TARGET DRUGGABLE?

Dr. Christine Allen

Dr. Ruth Ross

Dr. Daniel Small

Dr. Lakshmi Kotra